Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Morphic Holding, Inc.

MORFNASDAQ
Healthcare
Biotechnology
$56.99
$0.02(0.04%)
U.S. Market is Open • 14:02

Morphic Holding, Inc. (MORF) Stock Overview

Explore Morphic Holding, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.9B
P/E Ratio-15.88
EPS (TTM)$-3.83
ROE-0.29%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$30.94

MORF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Morphic Holding, Inc. (MORF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $30.94.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -15.88 and a market capitalization of 2.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.04%
3-Month Change
115.46%
6-Month Change
65.00%
Year-to-Date (YTD) Change
96.99%
1-Year Change
3.39%
3-Year Change
-14.76%
5-Year Change
199.16%
All-Time (Max) Change
216.61%

Contact Information

781 996 0955
35 Gatehouse Drive, A2, Waltham, MA, 02451

Company Facts

1,280 Employees
IPO DateJun 27, 2019
CountryUS

Frequently Asked Questions